Selective inactivation of NF-κB in the liver using NF-κB decoy suppresses CCl<sub>4</sub>-induced liver injury and fibrosis
Gakuhei Son(Hyogo Medical University), Jiro Fujimoto(Harvard University), Yuji Iimuro(Yamanashi Prefectural Central Hospital), Ekihiro Seki(Cedars-Sinai Medical Center), Tadamichi Hirano(Hyogo Medical University), Yasufumi Kaneda(Osaka University)
American Journal of Physiology-Gastrointestinal and Liver Physiology
July 20, 2007
Cited by 120
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
|International Immunology|2008|480
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
|Journal of Clinical Investigation|1998|454